ReviewCurrent opinion in pharmacology2016

A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.

Stephen M Hatfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.